Total Payments
$5,630
2024 Payments
$328.97
Companies
35
Transactions
353
Medicare Patients
5,750
Medicare Billing
$554,797
Payment Breakdown by Category
Food & Beverage$5,576 (99.0%)
Education$35.88 (0.6%)
Consulting$17.93 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,576 | 348 | 99.0% |
| Education | $35.88 | 4 | 0.6% |
| Consulting Fee | $17.93 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,106 | 147 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $460.48 | 29 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $368.33 | 24 | $0 (2023) |
| PFIZER INC. | $337.77 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $300.30 | 18 | $0 (2023) |
| GENZYME CORPORATION | $223.52 | 10 | $0 (2024) |
| Celgene Corporation | $214.01 | 12 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $137.00 | 9 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $134.73 | 5 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $125.04 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $328.97 | 17 | ABBVIE INC. ($75.93) |
| 2023 | $995.91 | 55 | ABBVIE INC. ($303.60) |
| 2022 | $1,078 | 68 | ABBVIE INC. ($328.31) |
| 2021 | $703.90 | 48 | AbbVie Inc. ($486.85) |
| 2020 | $650.48 | 43 | AbbVie Inc. ($265.08) |
| 2019 | $790.59 | 53 | AbbVie, Inc. ($220.20) |
| 2018 | $508.29 | 33 | AbbVie, Inc. ($217.19) |
| 2017 | $573.42 | 36 | AbbVie, Inc. ($209.13) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 10/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: GI | ||||||
| 08/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Immunology | ||||||
| 05/23/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Medical Urology | ||||||
| 05/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: VIROLOGY | ||||||
| 04/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Immunology | ||||||
| 04/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Neuroscience | ||||||
| 02/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: INFLIXIMAB | ||||||
| 01/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Immunology | ||||||
| 01/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/17/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Immunology | ||||||
| 01/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 11/16/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: GI | ||||||
| 11/16/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Immunology | ||||||
| 10/04/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,577 | 2,034 | $866,619 | $153,657 |
| 2022 | 16 | 1,133 | 1,474 | $690,115 | $112,509 |
| 2021 | 17 | 1,330 | 1,708 | $720,203 | $131,604 |
| 2020 | 19 | 1,710 | 2,277 | $944,077 | $157,027 |
Total Patients
5,750
Total Services
7,493
Medicare Billing
$554,797
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 463 | $108,805 | $29,854 | 27.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 109 | 110 | $119,460 | $21,926 | 18.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 225 | 451 | $85,690 | $11,941 | 13.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 157 | 165 | $144,210 | $11,177 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 116 | $31,552 | $11,124 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 129 | 129 | $35,346 | $10,109 | 28.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 56 | 56 | $45,136 | $9,861 | 21.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 80 | 80 | $82,640 | $8,601 | 10.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $35,552 | $6,309 | 17.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 67 | 90 | $17,100 | $6,241 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $27,560 | $6,107 | 22.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 68 | 96 | $18,240 | $5,401 | 29.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 31 | 31 | $27,714 | $3,608 | 13.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $16,160 | $3,526 | 21.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 26 | $17,004 | $2,054 | 12.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 17 | $30,600 | $1,930 | 6.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 26 | $4,758 | $1,590 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $2,997 | $1,143 | 38.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $4,095 | $1,007 | 24.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $12,000 | $148.22 | 1.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 246 | 385 | $90,475 | $24,582 | 27.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 109 | 109 | $118,374 | $21,427 | 18.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 145 | 150 | $131,100 | $10,845 | 8.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 208 | 388 | $73,720 | $10,412 | 14.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 49 | 49 | $38,688 | $8,582 | 22.2% |
About Dr. Frank Lopez, M.D
Dr. Frank Lopez, M.D is a Gastroenterology healthcare provider based in Jasper, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497759039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Lopez, M.D has received a total of $5,630 in payments from pharmaceutical and medical device companies, with $328.97 received in 2024. These payments were reported across 353 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,576).
As a Medicare-enrolled provider, Lopez has provided services to 5,750 Medicare beneficiaries, totaling 7,493 services with total Medicare billing of $554,797. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Jasper, GA
- Active Since 06/10/2005
- Last Updated 10/13/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497759039
Products in Payments
- XIFAXAN (Drug) $402.32
- MAVYRET (Drug) $373.28
- DUPIXENT (Biological) $358.25
- Humira (Biological) $346.17
- XELJANZ (Drug) $337.77
- ENTYVIO (Biological) $303.64
- LINZESS (Drug) $284.35
- HUMIRA (Biological) $263.15
- ZEPOSIA (Drug) $214.01
- STELARA (Biological) $207.93
- SKYRIZI (Biological) $192.99
- CREON (Drug) $185.37
- Mavyret (Drug) $163.65
- RINVOQ (Biological) $156.94
- Linzess (Drug) $114.94
- OCALIVA (Drug) $110.82
- REMICADE (Biological) $92.37
- Cimzia (Drug) $86.40
- Amitiza (Drug) $82.37
- RELTONE 200 MG (Drug) $74.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.